Cargando…
Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis
Background: Human albumin (HA) infusion is potentially effective for the management of hyponatremia in liver cirrhosis, but the current evidence is very limited. Methods: In this retrospective study, 2414 cirrhotic patients who were consecutively admitted to our hospital between January 2010 and Jun...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821044/ https://www.ncbi.nlm.nih.gov/pubmed/36614908 http://dx.doi.org/10.3390/jcm12010107 |
_version_ | 1784865604249845760 |
---|---|
author | Bai, Zhaohui Xu, Wentao Chai, Lu Zheng, Xiaojie Méndez-Sánchez, Nahum Philips, Cyriac Abby Cheng, Gang Qi, Xingshun |
author_facet | Bai, Zhaohui Xu, Wentao Chai, Lu Zheng, Xiaojie Méndez-Sánchez, Nahum Philips, Cyriac Abby Cheng, Gang Qi, Xingshun |
author_sort | Bai, Zhaohui |
collection | PubMed |
description | Background: Human albumin (HA) infusion is potentially effective for the management of hyponatremia in liver cirrhosis, but the current evidence is very limited. Methods: In this retrospective study, 2414 cirrhotic patients who were consecutively admitted to our hospital between January 2010 and June 2014 were included in the Hospitalization outcome cohort, and 339 cirrhotic patients without malignancy who were consecutively admitted to our department between December 2014 and April 2021 were included in the Long-term outcome cohort. The development and improvement of hyponatremia were compared between patients who received HA infusion during hospitalizations and did not. Logistic and Cox regression analyses were performed to evaluate the association of development and improvement of hyponatremia during hospitalizations with the outcomes. Odds ratios (ORs) and hazard ratios (HRs) were calculated. Results: In the two cohorts, HA infusion significantly decreased the incidence of hyponatremia and increased the rate of improvement of hyponatremia in cirrhotic patients during hospitalizations. In the Hospitalization outcome cohort, the development of hyponatremia during hospitalizations was significantly associated with increased in-hospital mortality (OR = 2.493, p < 0.001), and the improvement of hyponatremia during hospitalizations was significantly associated with decreased in-hospital mortality (OR = 0.599, p = 0.014). In the Long-term outcome cohort, the development of hyponatremia during hospitalizations was significantly associated with decreased long-term survival (HR = 0.400, p < 0.001), and the improvement of hyponatremia during hospitalizations was not significantly associated with long-term survival (HR = 1.085, p = 0.813). Conclusions: HA infusion can effectively prevent the development of hyponatremia and improve hyponatremia in cirrhotic patients during hospitalizations, which may influence the patients’ outcomes. |
format | Online Article Text |
id | pubmed-9821044 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98210442023-01-07 Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis Bai, Zhaohui Xu, Wentao Chai, Lu Zheng, Xiaojie Méndez-Sánchez, Nahum Philips, Cyriac Abby Cheng, Gang Qi, Xingshun J Clin Med Article Background: Human albumin (HA) infusion is potentially effective for the management of hyponatremia in liver cirrhosis, but the current evidence is very limited. Methods: In this retrospective study, 2414 cirrhotic patients who were consecutively admitted to our hospital between January 2010 and June 2014 were included in the Hospitalization outcome cohort, and 339 cirrhotic patients without malignancy who were consecutively admitted to our department between December 2014 and April 2021 were included in the Long-term outcome cohort. The development and improvement of hyponatremia were compared between patients who received HA infusion during hospitalizations and did not. Logistic and Cox regression analyses were performed to evaluate the association of development and improvement of hyponatremia during hospitalizations with the outcomes. Odds ratios (ORs) and hazard ratios (HRs) were calculated. Results: In the two cohorts, HA infusion significantly decreased the incidence of hyponatremia and increased the rate of improvement of hyponatremia in cirrhotic patients during hospitalizations. In the Hospitalization outcome cohort, the development of hyponatremia during hospitalizations was significantly associated with increased in-hospital mortality (OR = 2.493, p < 0.001), and the improvement of hyponatremia during hospitalizations was significantly associated with decreased in-hospital mortality (OR = 0.599, p = 0.014). In the Long-term outcome cohort, the development of hyponatremia during hospitalizations was significantly associated with decreased long-term survival (HR = 0.400, p < 0.001), and the improvement of hyponatremia during hospitalizations was not significantly associated with long-term survival (HR = 1.085, p = 0.813). Conclusions: HA infusion can effectively prevent the development of hyponatremia and improve hyponatremia in cirrhotic patients during hospitalizations, which may influence the patients’ outcomes. MDPI 2022-12-23 /pmc/articles/PMC9821044/ /pubmed/36614908 http://dx.doi.org/10.3390/jcm12010107 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bai, Zhaohui Xu, Wentao Chai, Lu Zheng, Xiaojie Méndez-Sánchez, Nahum Philips, Cyriac Abby Cheng, Gang Qi, Xingshun Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis |
title | Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis |
title_full | Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis |
title_fullStr | Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis |
title_full_unstemmed | Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis |
title_short | Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis |
title_sort | effects of short-term human albumin infusion for the prevention and treatment of hyponatremia in patients with liver cirrhosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821044/ https://www.ncbi.nlm.nih.gov/pubmed/36614908 http://dx.doi.org/10.3390/jcm12010107 |
work_keys_str_mv | AT baizhaohui effectsofshorttermhumanalbumininfusionforthepreventionandtreatmentofhyponatremiainpatientswithlivercirrhosis AT xuwentao effectsofshorttermhumanalbumininfusionforthepreventionandtreatmentofhyponatremiainpatientswithlivercirrhosis AT chailu effectsofshorttermhumanalbumininfusionforthepreventionandtreatmentofhyponatremiainpatientswithlivercirrhosis AT zhengxiaojie effectsofshorttermhumanalbumininfusionforthepreventionandtreatmentofhyponatremiainpatientswithlivercirrhosis AT mendezsancheznahum effectsofshorttermhumanalbumininfusionforthepreventionandtreatmentofhyponatremiainpatientswithlivercirrhosis AT philipscyriacabby effectsofshorttermhumanalbumininfusionforthepreventionandtreatmentofhyponatremiainpatientswithlivercirrhosis AT chenggang effectsofshorttermhumanalbumininfusionforthepreventionandtreatmentofhyponatremiainpatientswithlivercirrhosis AT qixingshun effectsofshorttermhumanalbumininfusionforthepreventionandtreatmentofhyponatremiainpatientswithlivercirrhosis |